Mark your calendar!
On Friday, October 10th investigators will report clinical trial results from the Prevention of Retained Blood Outcomes with Active Clearance Technology (PROACT) assessing the use of PleuraFlow to...
View ArticleClearFlow announces positive clinical trial results for the reduction of...
Washington, DC.—October 10, 2014—ClearFlow Inc., a medical device company based in Anaheim, CA, today announced positive results from the Prevention of Retained Blood Outcomes Using Active Clearance...
View ArticleMaquet Medical Systems USA Announces Exclusive US Distribution Agreement with...
WAYNE, N.J., Jan. 23, 2015 /PRNewswire/ — Maquet Medical Systems USA announced today an exclusive US distribution agreement with ClearFlow, Inc. for its innovative PleuraFlow® Active Clearance...
View ArticleClearFlow Exhibits PleuraFlow System at Society of Thoracic Surgeons Annual...
Groundbreaking Device Designed to Prevent Retained Blood Syndrome Draws Crowds in San Diego Anaheim, CA – January 26, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, is currently...
View ArticleClearFlow’s PleuraFlow System Exhibited at Association of Physician...
Anaheim, CA – March 2, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, is currently exhibiting its innovative PleuraFlow® Active Clearance Technology® System at the 34th annual...
View ArticleClearFlow Employees Make a Stand For Heart Health At The American Heart...
Anaheim, CA – March 10, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, rallied its employees, their families and loved ones this past weekend in the name of heart health awareness...
View ArticleStudy Demonstrates Concern for Retained Blood Syndrome after Heart Surgery
Anaheim, CA – March 25, 2015—Cardiac anesthesia investigators from Germany presented data this week at the International Anesthesia Research Society’s (IARS) 2015 Annual Meeting and International...
View ArticleSurgeons Discuss High Readmission Rates for Patients with Retained Blood...
Seattle, WA–April 27, 2015—A panel of distinguished heart surgeons from leading cardiac centers shared their experiences and strategies to optimize patient recovery after cardiothoracic surgery at a...
View ArticleClinical Investigators at German Anesthesia Congress Report Increased Stays...
Anaheim, CA – May 11, 2015— ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that cardiac critical care investigators presented data last week at the 62nd annual...
View ArticleFDA Expands Label Indication for PleuraFlow to Reduce Retained Blood
Anaheim, CA – June 03, 2015— ClearFlow, Inc., a medical device company based in Anaheim, California, announced today that the United States Food & Drug Administration (FDA) has granted expanded...
View ArticleUnmet -Need for Chest Tube Patency Standards an Area of Focus at...
ClearFlow Participates in Clinical Panel Presentations and Round Table at Conference Focused on Clinical Impact of Retained Blood Washington, DC – October 6, 2015—ClearFlow Inc., a medical device...
View ArticleClearFlow’s PleuraFlow System Exhibited at European Association for...
Amsterdam, Netherlands – October 8, 2015—ClearFlow Inc., a medical device company based in Anaheim, California, USA, exhibited its innovative PleuraFlow® Active Clearance Technology® System at the 29th...
View ArticleClearFlow Exhibits PleuraFlow System at Society of Thoracic Surgeons Annual...
Groundbreaking Device Designed to Prevent Retained Blood Syndrome Draws Crowds in San Diego Anaheim, CA – January 26, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, is currently...
View ArticleClearFlow’s PleuraFlow System Exhibited at Association of Physician...
Anaheim, CA – March 2, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, is currently exhibiting its innovative PleuraFlow® Active Clearance Technology® System at the 34th annual...
View ArticleClearFlow Employees Make a Stand For Heart Health At The American Heart...
Anaheim, CA – March 10, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, rallied its employees, their families and loved ones this past weekend in the name of heart health awareness...
View ArticleNewly Published Study Confirms Reduction in Retained Blood and Postoperative...
Anaheim, CA – March 9, 2016—ClearFlow Inc., a medical device company based in Anaheim, California, has announced the publication of significantly positive results in a study evaluating the company’s...
View ArticleGetinge Group Receives Innovative Technology Designation from Novation for...
Designation recognizes the development of new solutions that benefit the healthcare industry WAYNE, N.J., March 29, 2016 /PRNewswire/ — Getinge Group announced its Maquet V8 Catheter and Maquet...
View ArticlePleuraFlow Relieves Life-Threatening Pericardial Tamponade by Active...
Anaheim, CA – March 30, 2016—Cardiac Surgeons at the Montreal Heart Institute have published a report featured in this month’s Annals of Thoracic Surgery detailing how active clearance of chest tubes...
View ArticleStudy Reveals Retained Blood as Common Culprit Leading to Acquired Infections...
— ClearFlow Executive Comments on Possible Solutions to Hospital Acquired Infections — Anaheim, CA – April 6, 2016—Cardiac anesthesia investigators from Germany presented data revealing the role...
View ArticleNew Data Indicates Patients with Retained Blood are 75% More Likely to Suffer...
— ClearFlow Executives Comment on Need for New Protocols — Anaheim, CA – April 13, 2016—Clinical data presented at the Society of Cardiovascular Anesthesiologists (SCA) 2016 Annual Meeting and...
View Article
